Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared Moss

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|January 29, 2026
Calcium tartrate tetrahydrate bladder stoneSteele Netterville, Jacob Stevens, Preston Royce Barron, et al.
World Journal of Methodology|July 4, 2015
Ability of community-based prostate cancer screening to target an appropriate and underserved populationJared Moss, Eric Heidel, Jason Johnson, et al.
The Journal of Sexual Medicine|January 20, 2025
Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasiaOlivia Copelan, Jared Moss, Sheldon Freedman, et al.
The Journal of Urology|August 9, 2023
Reply by AuthorsSteven A Kaplan, Jared Moss, Sheldon Freedman, et al.
The Journal of Urology|August 9, 2023
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaSteven A Kaplan, Jared Moss, Sheldon Freedman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|January 29, 2026
Calcium tartrate tetrahydrate bladder stoneSteele Netterville, Jacob Stevens, Preston Royce Barron, et al.
World Journal of Methodology|July 4, 2015
Ability of community-based prostate cancer screening to target an appropriate and underserved populationJared Moss, Eric Heidel, Jason Johnson, et al.
The Journal of Sexual Medicine|January 20, 2025
Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasiaOlivia Copelan, Jared Moss, Sheldon Freedman, et al.
The Journal of Urology|August 9, 2023
Reply by AuthorsSteven A Kaplan, Jared Moss, Sheldon Freedman, et al.
The Journal of Urology|August 9, 2023
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaSteven A Kaplan, Jared Moss, Sheldon Freedman, et al.
Pageof 1